Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial [Image: see text] ()

BACKGROUND: BC2001, the largest randomised trial of bladder-sparing treatment for muscle-invasive bladder cancer, demonstrated improvement of local control and bladder cancer–specific survival from the addition of concomitant 5-fluorouracil and mitomycin C to radiotherapy. OBJECTIVE: To determine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Huddart, Robert A., Hall, Emma, Lewis, Rebecca, Porta, Nuria, Crundwell, Malcolm, Jenkins, Peter J., Rawlings, Christine, Tremlett, Jean, Campani, Leila, Hendron, Carey, Hussain, Syed A., James, Nicholas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983941/
https://www.ncbi.nlm.nih.gov/pubmed/31843338
http://dx.doi.org/10.1016/j.eururo.2019.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983941/
https://www.ncbi.nlm.nih.gov/pubmed/31843338
http://dx.doi.org/10.1016/j.eururo.2019.11.001

Ejemplares similares